BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
2506996
Number of visits today
685
Number of downloads
1688881
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Brzozowa-Zasada M, Kurek J, Piecuch A, Wyrobiec G. The clinical and prognostic evaluation of GRP94 immunoexpression in Caucasian patients with colorectal adenocarcinoma. Prz Gastroenterol 2019;14:140-7. [PMID: 31616529 DOI: 10.5114/pg.2019.85898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kim JW, Cho YB, Lee S. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021;10:670. [PMID: 33802964 DOI: 10.3390/cells10030670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Brzozowa-Zasada M. Immunohistochemical expression of Snail1 protein in colorectal adenocarcinoma samples and its prognostic activity in Caucasian patients. Prz Gastroenterol 2021;16:339-45. [PMID: 34976242 DOI: 10.5114/pg.2021.111765] [Reference Citation Analysis]
3 Zhu X, Yi K, Hou D, Huang H, Jiang X, Shi X, Xing C. Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with Colorectal Tumors. Med Sci Monit 2020;26:e923828. [PMID: 32753569 DOI: 10.12659/MSM.923828] [Reference Citation Analysis]
4 Zhu X, Zhou G, Ma M, Hou D, Huang H, Jiang X, Xing PhD C. Clinicopathological Analysis and Prognostic Assessment of TCN1 in Patients with Gastric Cancer. Surg Innov 2021;:15533506211045318. [PMID: 34549663 DOI: 10.1177/15533506211045318] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345